CHANGE TO PAR-03-007 NOVEL GENETIC METHODS TO MAP FUNCTIONAL NEURONAL
CIRCUITS AND SYNAPTIC CHANGE
RELEASE DATE: November 18, 2003
NOTICE: NOT-DA-04-003
National Institute on Drug Abuse (NIDA)
(http://www.nida.nih.gov)
PURPOSE
The purpose of this notice is to alert the scientific community that
effective immediately, any R21 application submitted under the NOVEL
GENETIC METHODS TO MAP FUNCTIONAL NEURONAL CIRCUITS AND SYNAPTIC CHANGE
program announcement, PAR-03-007, published in the NIH Guide for
Contracts and Grants on October 10, 2002, at
http://grants.nih.gov/grants/guide/pa-files/PA-03-107.html must use
the NIH EXPLORATORY/DEVELOPMENTAL RESEARCH GRANT AWARD (R21) program
announcement (see http://grants.nih.gov/grants/guide/pa-files/PA-03-107.html).
The NIDA Exploratory/Developmental program announcement
cited in PAR-03-007 is no longer active.
This change does not affect special announcements such as the Cutting
Edge Basic Research Award (CEBRA), the Behavioral Science Track Award
for Rapid Transition (B/START) or Imaging - Science Track Award For
Research Transition (I/START) Program Announcements (see
http://www.drugabuse.gov/funding/resfundslist.html for details on these
programs).
o Direct your questions about this notice to:
Office of Extramural Affairs
National Institute on Drug Abuse/NIH/DHHS
6101 Executive Boulevard, Room 220, MSC 8401
Bethesda, MD 20892-8401
Telephone: 301-443-2755
Email: jporter@mail.nih.gov